ADIM
NKE icon

Alpha DNA Investment Management’s Nike NKE Stock Holding History

Alpha DNA Investment Management’s Portfolio NKE Stock Details NKE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-7,219
Closed -$959K – 446
2021
Q1 		$959K Buy
7,219
+6,812
+1,674% +$947K 1.1% 10
2020
Q4 		$57K Buy
+407
New +$53.9K 0.06% 165

Other funds holding NKE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Alpha DNA Investment Management's NKE Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Nike (NKE) in Q2 2021, closing a stake of 7,219 shares — an estimated $959K sold.

Alpha DNA Investment Management first reported a position in NKE in Q4 2020 and held it in 2 quarters. The position peaked at $959K in Q1 2021. 2,250 funds tracked by Wall St. Rank hold NKE as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Nike position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 7,219 Nike shares in Q2 2021, an estimated $959K.
  • Alpha DNA Investment Management first reported a position in Nike in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's Nike position peaked at $959K in Q1 2021.
  • 2,250 funds tracked by Wall St. Rank held Nike as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.